Australia Ophthalmic Device Market Size By Surgical Devices (Glaucoma Drainage Devices, Intraocular Lenses), By Diagnostic and Monitoring Devices (Autorefractors and Keratometers, Corneal Topography Systems, Ophthalmic Ultrasound Imaging Systems), By Geographic Scope and Forecast

Australia Ophthalmic Device Market Size and Forecast

Australia Ophthalmic Device Market size was valued at USD 1.88 Billion in 2024 and is projected to reach USD 2.8 Billion by 2031, growing at a CAGR of 5.5% from 2024 to 2031.

• Ophthalmic devices are a collection of specialized tools and instruments used to diagnose, treat, and manage a variety of eye problems. These technologies include diagnostic equipment like fundus cameras and optical coherence tomography (OCT) machines, surgical tools for operations like cataract extraction and laser treatments, and vision correction aids like contact lenses and corrective lenses.
• The increasing prevalence of vision-related problems, such as myopia, hyperopia, and age-related macular degeneration, has boosted the use of ophthalmic devices. Furthermore, the rise in chronic illnesses such as diabetes, which can result in diabetic retinopathy, has raised the need for early diagnosis and treatment devices.
• The development and integration of modern technologies such as artificial intelligence (AI) and robotic-assisted surgical systems are predicted to revolutionize ophthalmic treatments. AI-powered diagnostic technologies can improve disease diagnosis accuracy, while robotic procedures promise greater precision and faster recovery times. Personalized and bespoke eye treatments are also becoming more popular, with doctors using patient-specific data to improve surgery outcomes and treatment programs.

To Get Detailed Analysis: Download Report PDF

Australia Ophthalmic Device Market Dynamics

The key market dynamics that are shaping the Australia ophthalmic device market include:

Key Market Drivers:

• Increasing Prevalence of Age-Related Eye Disorders: The aging population in Australia is a key driver of the ophthalmic device market. According to the Australian Bureau of Statistics, the population aged 65 and up is expected to grow from 15.9% in 2020 to 22.2% in 2030. According to the National Health and Medical Research Council, roughly 170,000 Australians suffer from age-related macular degeneration (AMD), which is anticipated to increase to 220,000 by 2025. Furthermore, the Australian Institute of Health and Welfare reported that glaucoma affects 300,000 Australians, with half of cases going untreated, increasing the demand for better ophthalmic diagnostic and treatment technology.
• Technological Advances and Government Healthcare Innovation: The Australian government’s commitment to medical technology innovation is considerably boosting the ophthalmic device sector. The Department of Health and Aged Care has been aggressively supporting medical device innovation through its Medical Research Future Fund, which will provide AUD 480 million for medical technology research in 2022. The Therapeutic Goods Administration (TGA) has simplified the regulatory procedure for novel medical devices, resulting in a 35% increase in ophthalmic device approvals over the last three years.
• Rising Prevalence of Diabetes and Associated Eye Complications: The increasing incidence of diabetes in Australia is driving significant growth in the ophthalmic device market. The Australian Institute of Health and Welfare reports that 1.3 million Australians have diabetes, with diabetic retinopathy affecting approximately 30% of diabetes patients. The National Diabetes Services Scheme indicates that diabetic eye complications are a leading cause of preventable blindness, with over 75,000 new cases of diabetic retinopathy diagnosed annually.

Key Challenges:

• Costs and Accessibility Issues: Advanced ophthalmic technology, such as robotic surgical systems and laser technologies, can be expensive. This may limit their availability in smaller healthcare facilities or rural locations where there is a high need for vision treatment. Accessibility problems cause disparities in eye care quality across areas, influencing patient outcomes.
• Regulatory and Reimbursement Barriers: New ophthalmic technologies frequently need to pass severe regulatory approval processes, such as those handled by Australia’s Therapeutic Goods Administration (TGA). Healthcare providers may struggle to implement innovative procedures and technology due to constrained payment regulations or delays.
• Shortage of Skilled Professionals: Advanced ophthalmic equipment requires highly skilled experts, such as surgeons and technicians, to use them effectively. Australia is experiencing a scarcity of ophthalmologist specialists, particularly in rural and remote locations, which may hinder the adoption of cutting-edge technologies and influence the delivery of quality care.

Key Trends:

• Teleophthalmology is Becoming Increasingly Popular: The increased use of telemedicine technologies, especially during and after the COVID-19 pandemic, has changed eye care delivery. Remote diagnostic tools and consultations are increasing in popularity, particularly in impoverished rural areas, enhancing access to eye care services.
• Advancements in Surgical Technology: Robot-assisted surgeries, femtosecond lasers for cataract treatments, and minimally invasive glaucoma surgeries (MIGS) are gaining popularity. These developments provide improved precision, shorter recovery periods, and better patient outcomes, fueling demand for cutting-edge technologies.
• Growing Attention to Myopia Management: The rising prevalence of myopia, particularly among youngsters, has prompted a greater emphasis on preventive and remedial procedures. This growing worry is being addressed by specialized lenses, orthokeratology treatments, and novel diagnostic equipment, indicating a move toward proactive eye health care.

What's inside a VMR
industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

>>> Ask For Discount @ – https://www.verifiedmarketresearch.com/ask-for-discount/?rid=472762

Australia Ophthalmic Device Market Regional Analysis

Here is a more detailed regional analysis of the Australia ophthalmic device market:

Sydney:

• Sydney is the dominant city in Australia’s Ophthalmic Device Sydney is the unchallenged leader in Australia’s ophthalmic device market, because of its extensive medical infrastructure and cutting-edge research skills. The city is home to more than 60% of Australia’s leading ophthalmological research facilities and medical device manufacturers, including the renowned Sydney Eye Hospital and the University of Sydney’s Ophthalmology Research Centre. According to the New South Wales Health Infrastructure report, Sydney has invested almost AUD 750 million in medical technology infrastructure over the last three years, with a sizable share going toward ophthalmic device development and advanced vision care technologies.
• The city’s dominance is reinforced by a strong ecosystem of medical innovation and strategic healthcare investments. The Sydney Medical Devices Partnering Hub, which is funded by the Australian government, has been essential in fostering technological developments in the ophthalmology industry. According to data from the Australian Government’s Department of Health, Sydney-based medical device company’s account for 52.3% of the national ophthalmic device market, with around 45 specialized ophthalmic device manufacturers and research institutions concentrated in the metropolitan area.
• The city’s medical research institutions, including the Prince of Wales Medical Research Institute and the Australian Institute of Health Innovation, have played critical roles in developing groundbreaking ophthalmic technologies, cementing Sydney’s position as the dominant city in the Australian Ophthalmic Device Market.

Melbourne:

• Melbourne is the fastest-growing city in the Australia Ophthalmic Device Melbourne has emerged as a market leader in Australia’s ophthalmic device market, thanks to its world-class medical research infrastructure and innovative ecosystem. The city has experienced an impressive yearly growth rate of 14.6% in the ophthalmic device sector, exceeding national standards.
• According to the Victorian Department of Jobs, Precincts, and Regions, Melbourne has received more than AUD 420 million in medical technology investments over the last two years, with a strong emphasis on innovative ophthalmic devices and vision care technologies. The city’s growth is mostly driven by its world-renowned academic institutions and a strong network of medical technology inventors. The University of Melbourne and Monash University have played important roles in pushing pioneering research in ophthalmology, with their medical research institutes developing numerous breakthrough breakthroughs in diagnostic and treatment equipment.
• According to the Australian Medical Technology and Pharmaceuticals Growth Centre (MTP Connect), medical device businesses based in Melbourne increased their ophthalmic market share by 17.2%. The Victorian Government’s strategic medical innovation initiatives have accelerated this growth by offering targeted support and incentives to companies developing cutting-edge ophthalmic technologies, cementing Melbourne’s position as the fastest-growing city in the Australian Ophthalmic Device Market.

Australia Ophthalmic Device Market: Segmentation Analysis

The Australia Ophthalmic Device Market is segmented based on Surgical Devices, Diagnostic and Monitoring Devices, and Geography.

Australia Ophthalmic Device Market, By Surgical Devices

• Glaucoma Drainage Devices
• Intraocular Lenses

Based on the Surgical Devices, the Australia Ophthalmic Device Market is bifurcated into Glaucoma Drainage Devices and Intraocular Lenses. Intraocular lenses are a dominant segment of the Australia ophthalmic device market. Due to the high frequency of cataracts in the elderly population and the routine nature of cataract surgeries, which are one of the most popular ophthalmic treatments worldwide. IOLs are critical for restoring vision after surgery and are becoming increasingly popular due to sophisticated alternatives such as multifocal and toric lenses, which correct refractive problems.

Australia Ophthalmic Device Market, By Diagnostic and Monitoring Devices

• Autorefractors and Keratometers
• Corneal Topography Systems
• Ophthalmic Ultrasound Imaging Systems

Based on the Diagnostic and Monitoring Devices, the Australia Ophthalmic Device Market is bifurcated into Autorefractors and Keratometers, Corneal Topography Systems, and Ophthalmic Ultrasound Imaging Systems. Autorefractors and Keratometers dominate the diagnostic and monitoring devices segment in Australia. They are commonly used in routine eye exams and can evaluate refractive errors and corneal curvature quickly and reliably. These devices are used in both ophthalmology and optometry to prescribe glasses or contact lenses, making them a standard in eye care. Their supremacy over corneal topography and ocular ultrasound imaging systems, which are more specialized and utilized largely for complex or specific situations, is due to their versatility, ease of use, and capacity to speed diagnoses.

Australia Ophthalmic Device Market, By Geography

• Sydney

Sydney is the dominant city in Australia Ophthalmic Device Sydney is the unchallenged leader in Australia’s ophthalmic device market, because of its extensive medical infrastructure and cutting-edge research skills. The city is home to more than 60% of Australia’s leading ophthalmological research facilities and medical device manufacturers, including the renowned Sydney Eye Hospital and the University of Sydney’s Ophthalmology Research Centre. According to the New South Wales Health Infrastructure report, Sydney has invested almost AUD 750 million in medical technology infrastructure over the last three years, with a sizable share going toward ophthalmic device development and advanced vision care technologies.

Key Players

The “Australia Ophthalmic Device Market” study report will provide valuable insight with an emphasis on the global market.  The major players in the market are Alcon, Bausch + Lomb, Johnson & Johnson Vision, Carl Zeiss Meditec, Topcon Corporation, EssilorLuxottica, CooperVision, Nidek Co., Ltd., STAAR Surgical, and Glaukos Corporation.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Australia Ophthalmic Device Market Key Developments

• In March 2022, Rayner, a British manufacturer and distributor of intraocular lenses (IOLs) and ophthalmic solutions, opened a regional office in Sydney to directly supervise product distribution.
• In October 2021, SEED Co., Ltd. introduced a new SEED 1-day Silfa silicone hydrogel daily disposable contact lens in Australia. SEED 1day Silfa has a low modulus, enabling great fitting characteristics and all-day comfort.

Report Scope

Research Methodology of Verified Market Research:

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our Sales Team at Verified Market Research.

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

• In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.